Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. Among authors: gerbens laa. JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211. JAMA Dermatol. 2022. PMID: 36223090
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA, Boyce AE, Wall D, Barbarot S, de Booij RJ, Deleuran M, Middelkamp-Hup MA, Roberts A, Vestergaard C, Weidinger S, Apfelbacher CJ, Irvine AD, Schmitt J, Williamson PR, Spuls PI, Flohr C. Gerbens LA, et al. Trials. 2017 Feb 27;18(1):87. doi: 10.1186/s13063-016-1765-7. Trials. 2017. PMID: 28241851 Free PMC article.
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries.
Spuls PI, Gerbens LAA, Apfelbacher CJ, Wall D, Arents BWM, Barbarot S, Roberts A, Deleuran M, Middelkamp-Hup MA, Vestergaard C, Weidinger S, Schmitt J, Irvine AD, Flohr C. Spuls PI, et al. Among authors: gerbens laa. J Invest Dermatol. 2017 Sep;137(9):2014-2016. doi: 10.1016/j.jid.2017.05.014. Epub 2017 May 27. J Invest Dermatol. 2017. PMID: 28558913 Free article. No abstract available.
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Furue M, Gerbens LAA, Prinsen CAC, Schmitt J, Spuls PI, Thomas KS, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. Among authors: gerbens laa. J Am Acad Dermatol. 2020 May;82(5):1181-1186. doi: 10.1016/j.jaad.2019.12.055. Epub 2020 Jan 8. J Am Acad Dermatol. 2020. PMID: 31926221
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Bosma AL, de Wijs LEM, Hof MH, van Nieuwenhuizen BR, Gerbens LAA, Middelkamp-Hup MA, Hijnen D, Spuls PI. Bosma AL, et al. Among authors: gerbens laa. J Am Acad Dermatol. 2020 Nov;83(5):1375-1384. doi: 10.1016/j.jaad.2020.05.128. Epub 2020 May 30. J Am Acad Dermatol. 2020. PMID: 32485210 Free article.
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
Bosma AL, de Wijs LEM, Hof MH, van Nieuwenhuizen BR, Gerbens LAA, Middelkamp-Hup MA, Hijnen D, Spuls PI. Bosma AL, et al. Among authors: gerbens laa. J Am Acad Dermatol. 2021 Sep;85(3):e173-e174. doi: 10.1016/j.jaad.2021.02.072. Epub 2021 Mar 4. J Am Acad Dermatol. 2021. PMID: 33675862 No abstract available.
The HOME Core outcome set for clinical trials of atopic dermatitis.
Williams HC, Schmitt J, Thomas KS, Spuls PI, Simpson EL, Apfelbacher CJ, Chalmers JR, Furue M, Katoh N, Gerbens LAA, Leshem YA, Howells L, Singh JA, Boers M; HOME Initiative. Williams HC, et al. Among authors: gerbens laa. J Allergy Clin Immunol. 2022 Jun;149(6):1899-1911. doi: 10.1016/j.jaci.2022.03.017. Epub 2022 Mar 26. J Allergy Clin Immunol. 2022. PMID: 35351441 Free article.
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
Bosma AL, Musters AH, Bloem M, Gerbens LAA, Middelkamp-Hup MA, Haufe E, Schmitt J, Barbarot S, Seneschal J, Staumont-Sallé D, Johansson EK, Bradley M, von Kobyletzki LB, Vittrup I, Frier Ruge I, Thyssen JP, Vestergaard C, de Vega M, García-Doval I, Chiricozzi A, Stingeni L, Calzavara-Pinton P, Ardern-Jones MR, Reynolds NJ, Flohr C, Spuls PI. Bosma AL, et al. Among authors: gerbens laa. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):123-136. doi: 10.1111/jdv.18566. Epub 2022 Sep 10. J Eur Acad Dermatol Venereol. 2023. PMID: 36018221 Free PMC article.
46 results